ID   EPHA3_HUMAN             Reviewed;         983 AA.
AC   P29320; Q9H2V3; Q9H2V4;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   02-NOV-2010, entry version 128.
DE   RecName: Full=Ephrin type-A receptor 3;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH-like kinase 4;
DE            Short=EK4;
DE            Short=hEK4;
DE   AltName: Full=HEK;
DE   AltName: Full=Tyrosine-protein kinase TYRO4;
DE   AltName: Full=Tyrosine-protein kinase receptor ETK1;
DE   Flags: Precursor;
GN   Name=EPHA3; Synonyms=ETK, ETK1, HEK, TYRO4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-924.
RX   MEDLINE=92179233; PubMed=1311845; DOI=10.1073/pnas.89.5.1611;
RA   Wicks I.P., Wilkinson D., Salvaris E., Boyd A.W.;
RT   "Molecular cloning of HEK, the gene encoding a receptor tyrosine
RT   kinase expressed by human lymphoid tumor cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1611-1615(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Melanoma;
RX   MEDLINE=20441582; PubMed=10987298;
RA   Chiari R., Hames G., Stroobant V., Texier C., Maillere B., Boon T.,
RA   Coulie P.G.;
RT   "Identification of a tumor-specific shared antigen derived from an Eph
RT   receptor and presented to CD4 T cells on HLA class II molecules.";
RL   Cancer Res. 60:4855-4863(2000).
RN   [3]
RP   PROTEIN SEQUENCE OF 21-29 AND 840-860, AND CHARACTERIZATION.
RX   MEDLINE=92147681; PubMed=1737782;
RA   Boyd A.W., Ward L.D., Wicks I.P., Simpson R.J., Salvaris E., Wilks A.,
RA   Welch K., Loudovaris M., Rockman S., Busmanis I.;
RT   "Isolation and characterization of a novel receptor-type protein
RT   tyrosine kinase (hek) from a human pre-B cell line.";
RL   J. Biol. Chem. 267:3262-3267(1992).
RN   [4]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-779, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-779, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-37; SER-85; LEU-621 AND ASN-806.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-229; PHE-449; LEU-518; VAL-564;
RP   SER-568; PRO-590; GLU-766; GLY-777; HIS-914 AND ARG-924.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family. Binds to
CC       ephrin-A2, -A3, -A4 and -A5. Could play a role in lymphoid
CC       function.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P29320-1; Sequence=Displayed;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay;
CC       Name=2;
CC         IsoId=P29320-2; Sequence=VSP_002995, VSP_002996;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest level in placenta.
CC   -!- DISEASE: Defects in EPHA3 may be a cause of colorectal cancer
CC       (CRC) [MIM:114500].
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M83941; AAA58633.1; -; mRNA.
DR   EMBL; AF213459; AAG43576.1; -; mRNA.
DR   EMBL; AF213460; AAG43577.1; -; mRNA.
DR   IPI; IPI00219172; -.
DR   IPI; IPI00298105; -.
DR   PIR; A38224; A38224.
DR   RefSeq; NP_005224.2; -.
DR   RefSeq; NP_872585.1; -.
DR   UniGene; Hs.123642; -.
DR   PDB; 2GSF; X-ray; 1.77 A; A=577-947.
DR   PDB; 2QO2; X-ray; 1.60 A; A=577-947.
DR   PDB; 2QO7; X-ray; 1.60 A; A=577-947.
DR   PDB; 2QO9; X-ray; 1.55 A; A=577-947.
DR   PDB; 2QOB; X-ray; 1.65 A; A=606-947.
DR   PDB; 2QOC; X-ray; 1.25 A; A=606-947.
DR   PDB; 2QOD; X-ray; 1.15 A; A=577-947.
DR   PDB; 2QOF; X-ray; 1.20 A; A=577-947.
DR   PDB; 2QOI; X-ray; 1.25 A; A=577-947.
DR   PDB; 2QOK; X-ray; 1.20 A; A=577-947.
DR   PDB; 2QOL; X-ray; 1.07 A; A=577-947.
DR   PDB; 2QON; X-ray; 1.79 A; A=577-947.
DR   PDB; 2QOO; X-ray; 1.25 A; A=577-947.
DR   PDB; 2QOQ; X-ray; 1.60 A; A=577-947.
DR   PDB; 3DZQ; X-ray; 1.75 A; A=606-947.
DR   PDB; 3FXX; X-ray; 1.70 A; A=577-947.
DR   PDB; 3FY2; X-ray; 1.80 A; A=577-947.
DR   PDBsum; 2GSF; -.
DR   PDBsum; 2QO2; -.
DR   PDBsum; 2QO7; -.
DR   PDBsum; 2QO9; -.
DR   PDBsum; 2QOB; -.
DR   PDBsum; 2QOC; -.
DR   PDBsum; 2QOD; -.
DR   PDBsum; 2QOF; -.
DR   PDBsum; 2QOI; -.
DR   PDBsum; 2QOK; -.
DR   PDBsum; 2QOL; -.
DR   PDBsum; 2QON; -.
DR   PDBsum; 2QOO; -.
DR   PDBsum; 2QOQ; -.
DR   PDBsum; 3DZQ; -.
DR   PDBsum; 3FXX; -.
DR   PDBsum; 3FY2; -.
DR   ProteinModelPortal; P29320; -.
DR   SMR; P29320; 29-203, 319-529, 439-532, 908-983.
DR   DIP; DIP-40307N; -.
DR   STRING; P29320; -.
DR   PhosphoSite; P29320; -.
DR   PRIDE; P29320; -.
DR   Ensembl; ENST00000336596; ENSP00000337451; ENSG00000044524.
DR   GeneID; 2042; -.
DR   KEGG; hsa:2042; -.
DR   UCSC; uc003dqx.1; human.
DR   UCSC; uc003dqy.1; human.
DR   CTD; 2042; -.
DR   GeneCards; GC03P089239; -.
DR   H-InvDB; HIX0030735; -.
DR   HGNC; HGNC:3387; EPHA3.
DR   HPA; CAB010462; -.
DR   MIM; 114500; phenotype.
DR   MIM; 179611; gene.
DR   PharmGKB; PA27819; -.
DR   eggNOG; prNOG15214; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P29320; -.
DR   OMA; DMKKVGV; -.
DR   OrthoDB; EOG90GG94; -.
DR   PhylomeDB; P29320; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephrina_ephapathway; EphrinA-EPHA pathway.
DR   NextBio; 8295; -.
DR   ArrayExpress; P29320; -.
DR   Bgee; P29320; -.
DR   CleanEx; HS_EPHA3; -.
DR   Genevestigator; P29320; -.
DR   GermOnline; ENSG00000044524; Homo sapiens.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR011510; SAM_2.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020768; Tyr_prot_kinase_EphA_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF278; Tyr_prot_kinase_EphA_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07699; GCC2_GCC3; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS01186; EGF_2; UNKNOWN_1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Repeat; Secreted; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     20
FT   CHAIN        21    983       Ephrin type-A receptor 3.
FT                                /FTId=PRO_0000016802.
FT   TOPO_DOM     21    541       Extracellular (Potential).
FT   TRANSMEM    542    565       Helical; (Potential).
FT   TOPO_DOM    566    983       Cytoplasmic (Potential).
FT   DOMAIN      325    429       Fibronectin type-III 1.
FT   DOMAIN      437    528       Fibronectin type-III 2.
FT   DOMAIN      621    882       Protein kinase.
FT   DOMAIN      911    975       SAM.
FT   NP_BIND     627    635       ATP (By similarity).
FT   MOTIF       981    983       PDZ-binding (Potential).
FT   COMPBIAS    189    322       Cys-rich.
FT   ACT_SITE    746    746       Proton acceptor (By similarity).
FT   BINDING     653    653       ATP (By similarity).
FT   MOD_RES     596    596       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     602    602       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     779    779       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     937    937       Phosphotyrosine (By similarity).
FT   CARBOHYD    232    232       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    337    337       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    391    391       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    404    404       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    493    493       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ     532    539       SFSISGES -> CMYYFNAV (in isoform 2).
FT                                /FTId=VSP_002995.
FT   VAR_SEQ     540    983       Missing (in isoform 2).
FT                                /FTId=VSP_002996.
FT   VARIANT      37     37       T -> K (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_036086.
FT   VARIANT      85     85       N -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_036087.
FT   VARIANT     229    229       S -> Y (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042126.
FT   VARIANT     449    449       S -> F (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_042127.
FT   VARIANT     518    518       G -> L (in a lung squamous cell carcinoma
FT                                sample; somatic mutation; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_042128.
FT   VARIANT     564    564       I -> V (in dbSNP:rs55712516).
FT                                /FTId=VAR_042129.
FT   VARIANT     568    568       C -> S (in dbSNP:rs56077781).
FT                                /FTId=VAR_042130.
FT   VARIANT     590    590       L -> P (in dbSNP:rs56081642).
FT                                /FTId=VAR_042131.
FT   VARIANT     621    621       I -> L (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_036088.
FT   VARIANT     766    766       G -> E (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042132.
FT   VARIANT     777    777       A -> G (in dbSNP:rs34437982).
FT                                /FTId=VAR_042133.
FT   VARIANT     806    806       D -> N (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_036089.
FT   VARIANT     914    914       R -> H (in dbSNP:rs17801309).
FT                                /FTId=VAR_027919.
FT   VARIANT     924    924       W -> R (in dbSNP:rs35124509).
FT                                /FTId=VAR_042134.
FT   CONFLICT    911    911       T -> S (in Ref. 1; AAA58633).
FT   TURN        610    612
FT   HELIX       618    620
FT   STRAND      621    629
FT   STRAND      631    641
FT   STRAND      647    654
FT   HELIX       661    674
FT   STRAND      685    689
FT   STRAND      691    694
FT   STRAND      696    700
FT   HELIX       707    712
FT   TURN        713    716
FT   HELIX       720    739
FT   HELIX       749    751
FT   STRAND      752    754
FT   STRAND      760    762
FT   HELIX       788    790
FT   HELIX       793    798
FT   HELIX       803    818
FT   TURN        824    827
FT   HELIX       830    838
FT   HELIX       851    860
FT   HELIX       865    867
FT   HELIX       871    883
FT   HELIX       885    889
FT   STRAND      898    903
SQ   SEQUENCE   983 AA;  110131 MW;  BE04DBF958245424 CRC64;
     MDCQLSILLL LSCSVLDSFG ELIPQPSNEV NLLDSKTIQG ELGWISYPSH GWEEISGVDE
     HYTPIRTYQV CNVMDHSQNN WLRTNWVPRN SAQKIYVELK FTLRDCNSIP LVLGTCKETF
     NLYYMESDDD HGVKFREHQF TKIDTIAADE SFTQMDLGDR ILKLNTEIRE VGPVNKKGFY
     LAFQDVGACV ALVSVRVYFK KCPFTVKNLA MFPDTVPMDS QSLVEVRGSC VNNSKEEDPP
     RMYCSTEGEW LVPIGKCSCN AGYEERGFMC QACRPGFYKA LDGNMKCAKC PPHSSTQEDG
     SMNCRCENNY FRADKDPPSM ACTRPPSSPR NVISNINETS VILDWSWPLD TGGRKDVTFN
     IICKKCGWNI KQCEPCSPNV RFLPRQFGLT NTTVTVTDLL AHTNYTFEID AVNGVSELSS
     PPRQFAAVSI TTNQAAPSPV LTIKKDRTSR NSISLSWQEP EHPNGIILDY EVKYYEKQEQ
     ETSYTILRAR GTNVTISSLK PDTIYVFQIR ARTAAGYGTN SRKFEFETSP DSFSISGESS
     QVVMIAISAA VAIILLTVVI YVLIGRFCGY KSKHGADEKR LHFGNGHLKL PGLRTYVDPH
     TYEDPTQAVH EFAKELDATN ISIDKVVGAG EFGEVCSGRL KLPSKKEISV AIKTLKVGYT
     EKQRRDFLGE ASIMGQFDHP NIIRLEGVVT KSKPVMIVTE YMENGSLDSF LRKHDAQFTV
     IQLVGMLRGI ASGMKYLSDM GYVHRDLAAR NILINSNLVC KVSDFGLSRV LEDDPEAAYT
     TRGGKIPIRW TSPEAIAYRK FTSASDVWSY GIVLWEVMSY GERPYWEMSN QDVIKAVDEG
     YRLPPPMDCP AALYQLMLDC WQKDRNNRPK FEQIVSILDK LIRNPGSLKI ITSAAARPSN
     LLLDQSNVDI TTFRTTGDWL NGVWTAHCKE IFTGVEYSSC DTIAKISTDD MKKVGVTVVG
     PQKKIISSIK ALETQSKNGP VPV
//
